INTRAHEPATIC CHOLESTASIS OF PREGNANCY Genetic background, epidemiology and hepatobiliary consequences
نویسندگان
چکیده
................................................................................................... 8 INTRODUCTION ......................................................................................... 9 REVIEW OF THE LITERATURE ................................................................. 10 1. Physiology of bile acids ............................................................................. 10 1.2. Enterohepatic circulation .................................................................. 11 1.3. Transporter mechanisms ................................................................... 13 1.3.1. Basolateral membranes of hepatocytes .................................. 13 1.3.2. Canalicular membranes of hepatocytes ................................. 15 1.3.3. Intestinal transport ................................................................. 15 1.3.4. Regulation ............................................................................... 16 2. Intrahepatic cholestasis ............................................................................. 16 2.1. Intrahepatic cholestatic diseases ....................................................... 17 2.2. Familial cholestatic diseases .............................................................. 17 3. Liver during pregnancy ............................................................................. 21 3.1. Intrahepatic cholestasis of pregnancy .............................................. 21 3.1.1. Epidemiology .......................................................................... 22 3.1.2. Pathogenesis ............................................................................ 22 3.1.3. Genetics ................................................................................... 22 3.1.4. Clinical picture and treatment ............................................... 23 3.1.5. Associated hepatobiliary disorders ......................................... 24 3.2. Other liver diseases and pregnancy .................................................. 25 4. Postmenopausal hormone therapy and liver proteins ............................ 26 4.1. Sex hormone-binding globulin ........................................................ 26 4.2. C-reactive protein .............................................................................. 27 AIMS OF THE STUDY .................................................................................. 29 SUBJECTS AND METHODS ....................................................................... 30 1. Subjects ...................................................................................................... 30 2. Methods ..................................................................................................... 32 2.1.1. Linkage analysis ................................................................................... 32 2.1.2. Polymerase chain reaction .................................................................. 33 2.2. Hormone therapy protocol .................................................................... 33 2.3. Assays ...................................................................................................... 34 3. Statistical analyses ..................................................................................... 34 RESULTS ........................................................................................................ 36 1. Genetics ..................................................................................................... 36 2. Incidence and risk factors ......................................................................... 37 3. The effect of hormone therapy on sex hormone-binding globulin ....... 38 4. The effect of hormone therapy on C-reactive protein ............................ 40 5. Associated liver and biliary diseases ......................................................... 40 DISCUSSION ................................................................................................ 41 CONCLUSIONS ............................................................................................ 46 ACKNOWLEDGEMENTS ............................................................................ 47 REFERENCES ................................................................................................ 49 ORIGINAL PUBLICATIONS ....................................................................... 59
منابع مشابه
Intrahepatic cholestasis of pregnancy: a past and present riddle.
Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific disorders that occurs mainly in the third trimester of pregnancy and is characterized by pruritus and elevated bile acid levels. ICP is regarded as a benign disease with no meaningful consequences to the mother but associated to an increased perinatal risk with increased rates of fetal morbidity and mortality. The pathogenesis ...
متن کاملTranscriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
Hepatobiliary transport systems mediate hepatic uptake and biliary excretion of bile acids, bilirubin and other biliary constituents. Hereditary or acquired defects of these transporters may cause or maintain cholestasis and jaundice under various clinical conditions including progressive familial intrahepatic cholestasis (PFIC) 1-3 or its milder forms, benign recurrent intrahepatic cholestasis...
متن کاملThe Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study.
BACKGROUND & AIMS Little is known in the United States about the epidemiology of liver diseases that develop only during (are unique to) pregnancy. We investigated the incidence of liver diseases unique to pregnancy in Olmsted County, Minnesota, and long-term maternal and fetal outcomes. METHODS We identified 247 women with liver diseases unique to pregnancy from 1996 through 2010 using the R...
متن کاملCholestasis during pregnancy: rare hepatic diseases unmasked by pregnancy.
The occurrence of cholestasis during pregnancy may be due to several disorders. These include pregnancyspecific diseases, like intrahepatic cholestasis of pregnancy(ICP), as well as to other causes such as oligosymptomatic choledocolitiasis, viral hepatitis and other underlying liver disorders like primary biliary cirrhosis. In recent years, the discovery of mutations in hepatobiliary transport...
متن کاملDisodium gadoxetate uptake in progressive familial intrahepatic cholestasis type I: Enhancing our understanding of the cholestatic disease
Hepatocyte-specific magnetic resonance imaging (MRI) contrast agents are commonly used to depict anatomic hepatobiliary lesions and are also useful in characterizing the kinetics of hepatocyte uptake and excretion. We report a case of a 13-year old female with progressive familial intrahepatic cholestasis (PFIC) type 1 who demonstrated decreased uptake and excretion of gadoxetate disodium contr...
متن کامل